Atorvastatin versus rosuvastatin in hypercholesterolaemic patients with or without the 3'UTR/lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) polymorphism

Trial Profile

Atorvastatin versus rosuvastatin in hypercholesterolaemic patients with or without the 3'UTR/lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) polymorphism

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Mar 2011

At a glance

  • Drugs Atorvastatin (Primary) ; Rosuvastatin (Primary)
  • Indications Hypercholesterolaemia
  • Focus Pharmacodynamics; Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 22 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top